Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.5.1.3 (
dihydrofolate reductase
)
5,819
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The ubiquitin-like modifier
FAT10
targets proteins for degradation by the proteasome, a process accelerated by the UBL-UBA domain protein NEDD8 ultimate buster 1-long. Here, we show that
FAT10
-mediated degradation occurs independently of poly-ubiquitylation as purified 26S proteasome readily degraded
FAT10
-
dihydrofolate reductase
(
DHFR
) but not ubiquitin-
DHFR
in vitro. Interestingly, the 26S proteasome could only degrade
FAT10
-
DHFR
when NUB1L was present. Knock-down of NUB1L attenuated the degradation of
FAT10
-
DHFR
in intact cells suggesting that NUB1L determines the degradation rate of
FAT10
-linked proteins. In conclusion, our data establish
FAT10
as a ubiquitin-independent but NUB1L-dependent targeting signal for proteasomal degradation.
...
PMID:Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L. 1916 48
Mutations in AIPL1 cause the inherited blindness Leber congenital amaurosis (LCA). AIPL1 has previously been shown to interact with NUB1, which facilitates the proteasomal degradation of proteins modified with the ubiquitin-like protein FAT10. Here we report that AIPL1 binds non-covalently to free
FAT10
and FAT10ylated proteins and can form a ternary complex with
FAT10
and NUB1. In addition, AIPL1 antagonised the NUB1-mediated degradation of the model
FAT10
conjugate,
FAT10
-
DHFR
, and pathogenic mutations of AIPL1 were defective in inhibiting this degradation. While all AIPL1 mutants tested still bound
FAT10
-
DHFR
, there was a close correlation between the ability of the mutants to interact with NUB1 and their ability to prevent NUB1-mediated degradation. Interestingly, AIPL1 also co-immunoprecipitated the E1 activating enzyme for
FAT10
, UBA6, suggesting AIPL1 may have a role in directly regulating the
FAT10
conjugation machinery. These studies are the first to implicate
FAT10
in retinal cell biology and LCA pathogenesis, and reveal a new role of AIPL1 in regulating the
FAT10
pathway.
...
PMID:The inherited blindness protein AIPL1 regulates the ubiquitin-like FAT10 pathway. 2234 7